Richard Walz - Gabelli Healthcare Chief Compliance Officer
| GRX Stock | USD 10.42 0.12 1.17% |
Executive
Mr. Richard J. Walz is Chief Compliance Officer of Gabelli Healthcare WellnessRx Trust., since November, 2013. Chief Compliance Officer of all of the registered investment companies GabelliGAMCO Fund Complex since 2013 Chief Compliance Officer of AEGON USA Investment Management, 20112013 Chief Compliance Officer of Cutwater Asset Management, 20042011. since 2013.
| Age | 60 |
| Tenure | 11 years |
| Address | One Corporate Center, Rye, NY, United States, 10580-1422 |
| Phone | 914 921 5000 |
| Web | https://www.gabelli.com/Template/fundinfo.cfm?tid= |
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| James Kirchner | Eaton Vance National | 54 | |
| Theron Hoffman | John Hancock Income | 72 | |
| Gregory Russo | John Hancock Income | 71 | |
| John Collins | Federated Premier Municipal | 73 | |
| Bruce CPA | GAMCO Natural Resources | 72 | |
| Maureen LallyGreen | Federated Premier Municipal | 71 | |
| Laurie Thomsen | MFS Investment Grade | 63 | |
| Thomas Faust | Eaton Vance National | 63 | |
| Ivan Arteaga | Gabelli MultiMedia Mutual | N/A | |
| Salvatore Schiavone | John Hancock Income | 55 | |
| Mario CFA | Gabelli MultiMedia Mutual | 82 | |
| CFA CFA | John Hancock Income | N/A | |
| Deborah Jackson | John Hancock Income | 68 | |
| Charles Bardelis | John Hancock Income | 79 | |
| William Cunningham | John Hancock Income | 76 | |
| Susan Pereira | MFS Investment Grade | 53 | |
| Charles Mansfield | Federated Premier Municipal | 74 | |
| Maureen Goldfarb | MFS Investment Grade | 65 | |
| Anthony Colavita | Gabelli Global Small | 58 | |
| Grace Fey | John Hancock Income | 74 | |
| Howard CFA | Gabelli MultiMedia Mutual | N/A | |
Management Performance
| Return On Equity | -13.74 |
Gabelli Healthcare Leadership Team
Elected by the shareholders, the Gabelli Healthcare's board of directors comprises two types of representatives: Gabelli Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Gabelli. The board's role is to monitor Gabelli Healthcare's management team and ensure that shareholders' interests are well served. Gabelli Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Gabelli Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bruce Alpert, President | ||
| CFA CFA, Portfolio Mang | ||
| Mario CFA, Portfolio Mang | ||
| Kuni Nakamura, Independent Trustee | ||
| David Schachter, Vice President | ||
| Bruce CPA, Ex Officer | ||
| Agnes Mullady, Principal Executive Officer and President Principal Financial Officer, Principal Accounting Officer and Treasurer | ||
| Daniel Plourde, Vice President | ||
| Calgary Avansino, Independent Trustee | ||
| Kevin Dreyer, Portfolio Mang | ||
| Adam Tokar, Vice President | ||
| Andrea Mango, Vice President, Secretary | ||
| Wayne CFA, Assistant Ombudsman | ||
| CPA CPA, Ex Officer | ||
| Salvatore Zizza, Independent Trustee | ||
| Mario Gabelli, Chairman of the Board of Trustees, Chief Investment Officer | ||
| Leslie Foley, Independent Trustee | ||
| Bethany Uhlein, Assistant Vice President and Ombudsman | ||
| Vincent Enright, Independent Director | ||
| Peter Goldstein, Vice President Secretary | ||
| Richard Walz, Chief Compliance Officer | ||
| Carter Austin, Vice President | ||
| James Conn, Lead Independent Trustee | ||
| Jeffrey Jonas, Trustee | ||
| Jonas CFA, Portfolio Mang | ||
| Anthonie Ekris, Independent Trustee | ||
| John Ball, Treasurer and Principal Financial and Accounting Officer | ||
| Robert Kolodny, Independent Trustee |
Gabelli Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Gabelli Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -13.74 | |||
| Shares Outstanding | 15.6 M | |||
| Shares Owned By Insiders | 1.54 % | |||
| Shares Owned By Institutions | 25.05 % | |||
| Number Of Shares Shorted | 8.44 K | |||
| Price To Earning | 4.15 X | |||
| Price To Book | 0.93 X | |||
| Price To Sales | 127.51 X | |||
| Revenue | 1.24 M | |||
| EBITDA | 3.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Gabelli Stock Analysis
When running Gabelli Healthcare's price analysis, check to measure Gabelli Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gabelli Healthcare is operating at the current time. Most of Gabelli Healthcare's value examination focuses on studying past and present price action to predict the probability of Gabelli Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gabelli Healthcare's price. Additionally, you may evaluate how the addition of Gabelli Healthcare to your portfolios can decrease your overall portfolio volatility.